Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von NightmareKing 

Teladoc Health Inc diskutieren

Teladoc Health Inc

WKN: A14VPK / Symbol: TDOC / Name: Teladoc Health / Aktie / Anbieter & Dienstleistungen / Mid Cap /

5,49 €
3,90 %

Einschätzung Buy
Rendite (%) -36,19 %
Kursziel 12,40
Veränderung
Endet am 04.12.25

Teladoc Health, Inc. (NYSE: TDOC) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $13.00 price target on the stock, up previously from $11.00.
Ratings data for TDOC provided by MarketBeat

Einschätzung Buy
Rendite (%) -43,27 %
Kursziel 11,41
Veränderung
Endet am 24.01.26

Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $14.00 to $12.00. They now have an "outperform" rating on the stock.
Ratings data for TDOC provided by MarketBeat

Einschätzung Buy
Rendite (%) -43,39 %
Kursziel 11,43
Veränderung
Endet am 24.01.26

Teladoc Health, Inc. (NYSE: TDOC) had its price target raised by analysts at Royal Bank of Canada from $11.00 to $12.00. They now have an "outperform" rating on the stock.
Ratings data for TDOC provided by MarketBeat

Einschätzung Buy
Rendite (%) -56,23 %
Kursziel 15,31
Veränderung
Endet am 18.02.26

Teladoc Health, Inc. (NYSE: TDOC) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $14.00 to $16.00. They now have a "buy" rating on the stock.
Ratings data for TDOC provided by MarketBeat

Einschätzung Buy
Rendite (%) -40,64 %
Kursziel 11,51
Veränderung
Endet am 27.02.26

Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Piper Sandler from $13.00 to $12.00. They now have an "overweight" rating on the stock.
Ratings data for TDOC provided by MarketBeat

Einschätzung Buy
Rendite (%) -40,95 %
Kursziel 12,40
Veränderung
Endet am 03.03.26

Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $16.00 to $13.00. They now have a "buy" rating on the stock.
Ratings data for TDOC provided by MarketBeat

Einschätzung Buy
Rendite (%) -11,86 %
Kursziel 8,84
Veränderung
Endet am 01.05.26

Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $13.00 to $10.00. They now have a "buy" rating on the stock.
Ratings data for TDOC provided by MarketBeat

Teladoc Health (NYSE:TDOC) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Ratings data for TDOC provided by MarketBeat